Product category:
Nucleic acid sequencing and synthesis
News Release from: Applied Biosystems | Subject: Expression Array System
Edited by the Laboratorytalk Editorial
Team on 09 May 2007
DNA microarray technology uncovers new
genes
Scientists at the Center for Medical Research, University Clinic Graz, have identified approximately 200 new genes associated with cell division, a process that, when uncontrolled, leads to cancer
The findings may help researchers better understand the causes of tumour formation as well as identify new therapeutic targets Christian Gully, leader of the molecular core facility at the Center for Medical Research, measured gene expression levels in cells at various stages of the cell cycle using DNA microarrays from Applied Biosystems
This article was originally published on Laboratorytalk on 14 Apr 2004 at 8.00am (UK)
Related stories
Worldwide availability of expression array system
Test site customers report that system can detect a greater number of genes with higher sensitivity and specificity than other microarray technologies
Analysing heart disease with array system
Dutch researchers use Expression Array System to identify genes that may predispose towards atherosclerosis, and validate them using TaqMan gene expression assays
In addition to finding genes already known to have a roll in mitosis, he identified more than 200 novel genes associated with cell division.
Gully used RNA interference (RNAi) techniques to discover the function of these genes in dividing cells.
Gully had previously attempted this experiment using other commercially available microarray platforms, but was dissatisfied with the results.
Further reading
Defining genome-wide events in leukaemia
Researchers at IHES and IRI use Expression Array System to understand gene regulatory events that are involved in the development of acute promyelocytic leukaemia on a genome-wide scale
High throughput nucleic acid purification
Applied Biosystems has released the ABI Prism 6100 nucleic acid PrepStation for high throughput purification of RNA and DNA, taking only 30 minutes to isolate total RNA from cells
"The results we obtained using the Applied Biosystems microarrays were clearly superior to the other systems," said Gully.
"And, after successfully validating the results by conventional PCR-based gene expression analyses, I have finally found a system I know I can count on".
The molecular core facility is the first Austrian institution to participate in the Applied Biosystems Advanced Gene Expression service provider programme.
The programme provides service providers with a comprehensive solution for gene expression analysis based on the highly sensitive Expression Array System for whole genome analysis and gold-standard TaqMan Gene Expression Assays for target validation, combined with technical and promotional support from Applied Biosystems.
In its two years as a service provider, the laboratory has already worked on more than 25 research projects from Europe and the USA.
The projects range from stem cell research to analysis of the impact of medicine, and are funded by several national and international bodies such as the Austrian genome research program (Gen-Au), the Austrian science fund (FWF), the Austrian central bank and the research program of the European Union.
In June, 2006, Quality Austria certified the laboratory for EN ISO/9001:2000, based on the facility's high standard of quality and reliability, raising its international profile considerably.
"Cooperation with internationally recognised laboratories is part of our ongoing strategy to support scientific research on a global basis," said Lars Holmkvist, president of Applied Biosystems, Europe.
"The Gene Expression service provider programme also allows other smaller research laboratories to access the advantages of our comprehensive solution for gene expression in a cost effective manner.".
• Applied Biosystems: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

